Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of lenalidomide and dexamethasone in the
treatment of patients with acute Myeloma (light chain)-induced renal failure.